Changsha export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
August 2025 — Vol. 2, No. 8
Page 2 of 4 of this archive, newest first.
Also filed — page 2
the rolling newsroom, August 2025Nigeria declines to reimburse tirzepatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What changed at QSC in August, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Medutest result on a Suzhou semaglutide lot lands 4.3 points below the supplier’s figure
The result is unremarkable. What the report omits is not.
From the floor in Guangzhou: 22 posters, one theme
Reported from the sessions, and from the two hours afterwards.
STEP 8 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Canada declines to reimburse semaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
Norway pharmacy body issues counselling standards for tirzepatide initiation
The evidence base is thin and the document says so, which is to its credit.
Medutest result on a Shanghai mazdutide lot lands 1.2 points below the supplier’s figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
What a 24% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.
A shortage listing ends. 10 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
SURMOUNT-2 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
Halvard & Pike Apothecary of Portland, Maine closes after 23 years
A proper account of an operation that existed, and of what closing it cost.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
A supplier suspends shipping to France after 7 consecutive customs detentions
The route did not close because of a rule about peptides.
The online reseller trading as Adamant Research Supply enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
Independent analysis puts a SSA dulaglutide lot at 96.0%, against 95.0% on the certificate
A reminder that a purity figure is the output of a method, and that methods differ.
A supplier suspends shipping to Turkey after 6 consecutive customs detentions
The route did not close because of a rule about peptides.
Wuhan export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Portugal declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The consolidator trading as Meridian Freight Partners closes after 19 years
A proper account of an operation that existed, and of what closing it cost.
What changed at WXT in August, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Medutest result on a Tianjin tirzepatide lot lands 4.3 points below the supplier’s figure
The supplier has not disputed the finding. It has not explained the gap either.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Independent analysis puts a WWB exenatide lot at 97.8%, against 95.3% on the certificate
The result is unremarkable. What the report omits is not.
Xi'an export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.